---
title: "William Blair upgrades Pyxis Oncology to Outperform from Market Perform"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/306274949.md"
description: "William Blair has upgraded Pyxis Oncology's stock rating from Market Perform to Outperform. This action follows recent analyst activity, with other firms like HC Wainwright & Co., RBC Capital, and Wedbush maintaining Buy or Outperform ratings over the past month. Price targets for the company currently range between $7 and $8."
datetime: "2026-11-20T12:26:25.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/306274949.md)
  - [en](https://longbridge.com/en/news/306274949.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/306274949.md)
generator: "portal-rs"
---

# William Blair upgrades Pyxis Oncology to Outperform from Market Perform

William Blair upgraded Pyxis Oncology to Outperform from Market Perform.

**Recent analyst actions on Pyxis Oncology**

| Date   | Firm                | Action     | Rating     | Price target |
| ------ | ------------------- | ---------- | ---------- | ------------ |
| Nov 20 | HC Wainwright & Co. | Reiterates | Buy        | $8           |
| Nov 6  | RBC Capital         | Maintains  | Outperform | $7           |
| Nov 6  | Wedbush             | Maintains  | Outperform | $7           |

Across the three most recent analyst notes published on Pyxis Oncology over the past 30 days, price targets range from $7 to $8.

Explore more price target data and ratings for Pyxis Oncology on the , and track all previous and future analyst recommendations in the dedicated News Flow.

**Disclaimer**

Select reference data provided by Benzinga. This information is not a recommendation for what you should do personally and does not constitute investment advice.

### Related Stocks

- [PYXS.US](https://longbridge.com/en/quote/PYXS.US.md)

## Related News & Research

- [PYXS: MICVO showed durable responses in phase 1, supporting a planned global Phase 3 trial](https://longbridge.com/en/news/306107284.md)
- [Guggenheim Remains a Buy on Pyxis Oncology (PYXS)](https://longbridge.com/en/news/306281515.md)
- [SanDisk Stock Price Forecast: TrendForce Sees 1Q27 NAND Contract Prices Flat to Down 5%, Shares Face About 40% Downside](https://longbridge.com/en/news/306297576.md)
- [AI solves 167-year-old maths problem, Anthropic researcher claims](https://longbridge.com/en/news/306318851.md)
- [Trump: 'Have lot of respect' for Anthropic, CEO Amodei](https://longbridge.com/en/news/306312307.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**